Financial Performance of Medical Corporations in Japan From 2016 to 2022: A Nationwide Longitudinal Analysis

Satoshi Funada, Shusuke Hiragi, Michiko Ashizawa, Rei Goto

Open source

DOI
10.2188/jea.je20250303
Published
2026-06-05
Container
Journal of Epidemiology
Publisher
Japan Epidemiological Association
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2188/jea.je20250303,
  title = {Financial Performance of Medical Corporations in Japan From 2016 to 2022: A Nationwide Longitudinal Analysis},
  author = {Satoshi Funada and Shusuke Hiragi and Michiko Ashizawa and Rei Goto},
  year = {2026},
  journal = {Journal of Epidemiology},
  doi = {10.2188/jea.je20250303},
  url = {https://doi.org/10.2188/jea.je20250303}
}

RIS

TY  - JOUR
TI  - Financial Performance of Medical Corporations in Japan From 2016 to 2022: A Nationwide Longitudinal Analysis
AU  - Satoshi Funada
AU  - Shusuke Hiragi
AU  - Michiko Ashizawa
AU  - Rei Goto
PY  - 2026
JO  - Journal of Epidemiology
DO  - 10.2188/jea.je20250303
UR  - https://doi.org/10.2188/jea.je20250303
ER  - 

APA

Funada, S., Hiragi, S., Ashizawa, M., & Goto, R. (2026). Financial Performance of Medical Corporations in Japan From 2016 to 2022: A Nationwide Longitudinal Analysis. Journal of Epidemiology. https://doi.org/10.2188/jea.je20250303

Source records